MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2026 International Congress

    Targeted IncobotulinumtoxinA Injections into the Muscle of Riolan: A Novel Rescue Strategy for Refractory Apraxia of Lid Opening in Neurodegenerative Disorders

    I. Miliukhina (Saint-Petersburg, Russian Federation)

    Objective: To evaluate the efficacy and durability of targeted incobotulinumtoxinA injections into the muscle of Riolan in patients with ALO refractory to conventional pretarsal BoNT-A…
  • 2026 International Congress

    Proposal of Anatomo-Functional Tremor Patterns for Ultrasound-Guided Botulinum Toxin Infiltration

    G. Salazar, I. Caballero (Terrassa, Spain)

    Objective: To propose a practical anatomo-functional framework for ultrasound-guided BoNT-A infiltration in upper limb tremor based on tremor biomechanics. Background: Botulinum toxin type A (BoNT-A)…
  • 2026 International Congress

    Clinical and Autonomic Correlates of Chronic Sialorrhea in Parkinson’s Disease: A Questionnaire-Based Study with Cluster Analysis of Autonomic and Dysphagia Burden

    S. Okusa, R. Okochi, Y. Sakai, T. Nukariya, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: To examine factors associated with drooling in patients with Parkinson’s disease (PD), patient awareness and perceptions of botulinum toxin therapy, and the relative contributions…
  • 2026 International Congress

    When Muscles Relax but Symptoms Persist: A Case of Dysfunctional Sensory-Motor Cortical Integration in Botulinum Toxin-Resistant Blepharospasm

    VD. Tkachenko, MZ. Makoeva (Moscow, Russian Federation)

    Objective: To present a case of blepharospasm (BSP) with objective response to serial botulinum toxin injections but persistent subjective symptoms, highlighting the role of sensory…
  • 2026 International Congress

    A Digital Toolkit for Movement Disorders Clinicians

    A. Lin, J. Patino, B. Talavera, Z. Yu, G. Brawerman, A. Koppanatham, C. Terrazas-Gamboa, A. Mahajan (Cincinnati, USA)

    Objective: To evaluate early adoption and real-world usage patterns of a digital toolkit designed for movement disorders clinicians Background: Movement disorders clinicians rely on multiple…
  • 2026 International Congress

    Rhythmic circular stump movements after traumatic amputation: jumping stump syndrome with rapid remission after botulinum toxin type A

    P. Muangsiri, P. Chairangsaris (Bangkok, Thailand)

    Objective: To describe the clinical phenomenology and treatment response of post-traumatic jumping stump syndrome following above-knee amputation. Background: Peripherally induced movement disorders are an underrecognized…
  • 2026 International Congress

    Outcomes of a new electromyography-guided botulinum toxin injection clinic for medication-refractory upper limb tremor

    R. Hoe, S. Neo (Singapore, Singapore)

    Objective: To describe the outcomes of a new electromyography (EMG)-guided botulinum toxin (BT) clinic for treatment of tremor in our center. Background: Tremor is often…
  • 2026 International Congress

    Digital Facial Movement Analysis in Hemifacial Spasm: Potential and Limitations as a Clinical Biomarker

    Z. Kosutzka, S. Sepelak, V. Hudzikova (Bratislava, Slovakia)

    Objective: To evaluate the potential use of digital biomarkers in the treatment assessment of hemifacial spasm (HFS) using botulinum toxin, also assessed with conventional methods…
  • 2026 International Congress

    Beyond Symptom Relief: Physician Empathy Outperforms Clinical Severity in Predicting Quality of Life for Patients Undergoing Botulinum Toxin Therapy

    T. Kölsche, R. Jansen, M. Ringelstein, S. Meuth, J. Lee, P. Albrecht (Düsseldorf, Germany)

    Objective: To evaluate the impact of patient-perceived physician empathy on health-related quality of life (HRQoL), treatment satisfaction, and clinical outcomes in patients receiving Botulinum Neurotoxin…
  • 2026 International Congress

    Five-Year Real-World Outcomes Of Botulinum Toxin Injections For Sialorrhoea In Parkinson’s

    R. Biju, B. Mohamed, J. Adenwalla, C. Thomas, S. Aviet (Cardiff, United Kingdom)

    Objective: 1. Assess real‑world outcomes of Botulinum Toxin A (BoNT-A) therapy for sialorrhoea in Parkinson’s disease by evaluating changes in Drooling Severity and Frequency Scale…
  • 1
  • 2
  • 3
  • …
  • 15
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley